Eva Yin joined BeiGene in 2022 as Chief Commercial Officer, BeiGene Greater China. Ms. Yin has nearly 20 years of experience in the pharmaceutical industry, having held various positions in finance, compliance, commercial & diversified channels, gaining insights into the development and characteristics of the healthcare industry.

Prior to BeiGene, Ms. Yin worked at AstraZeneca from 2006 to 2021, where she held various positions including Senior Business Finance Manager, Area Strategy Project Lead for International markets, Vice President of China & HK Compliance, and Vice President of Commercial & Diversified Channels. By Jan 2017, Eva expanded her responsibility to oversight of AstraZeneca HK & Macau. She was appointed AstraZeneca China Vice President, Oncology, in 2018, and promoted to General Manager of Oncology, AstraZeneca China, in 2019.

Ms. Yin graduated from Shanghai Jiao Tong University, majoring in finance & trading and computer science. She obtained her full-time MBA from CEIBS (China Europe International Business School) and completed an exchange program at London Business School in 2002.